CURRICULUM VITAE Personal Informationdas2017-nagoya.org/archives/001/201706/7034316d2b7... ·...

CURRICULUM VITAE Personal Information Name Dr Hin-Seng WONG Office Address Department of Nephrology, Hospital Selayang, Lebohraya Kepong Selayang

68100 Batu Caves Selangor Darul Ehsan,

MALAYSIA Telephone number (603) 6126 3333 Fax number (603) 6120 2761 e-mail address [email protected]

[email protected] Professional Qualifications MD (National University of Malaysia) 1988 Master in Medicine (Internal Medicine) [National University of Malaysia] 1994 Ministry of Health (Malaysia), Gazettement as Consultant Physician (Internal Medicine) 1994 MRCP (UK) 1997 Ministry of Health (Malaysia), Gazettement as Consultant Nephrologist 1998 Fellow of the Royal College of Physician of Edinburgh (FRCP Edin) 2005 Member of the Academy of Medicine, Malaysia 2008 Certified Medical Impairment Assessor (NIOSH) 2014 Post Graduate & Professional Experience Senior Registrar in Nephrology Nov 1996 – Oct 1997 Sheffield Kidney Institute Northern General Hospital, Sheffield, United Kingdom. Clinical Specialist (Registrar) in Nephrology, Jan 1994 – Oct 1996 Department of Nephrology, Hospital Kuala Lumpur Medical Officer (SHO), Medical Department, May 1990 – Dec 1993 National University of Malaysia, Kuala Lumpur Medical Officer (SHO), Medical Department Nov 1989 – April 1990 Hospital Taiping, Perak Medical Officer (SHO), Surgical Department, Aug 1989 – Oct 1989 Hospital Taiping, Perak House Officer, Medical, Paediatrics and O&G Department Aug 1988 – July 1989 Hospital Kuala Lumpur Position Held: Past and Present Deputy Head of National Nephrology Services April 2016 – Present Ministry of Health, Malaysia Head of the Selangor State Nephrology Services February 2016 – Present

mailto:[email protected]

Head, May 2010 – Present Clinical Research Centre Hospital Selayang, Selayang, Selangor Honorary Lecturer, June 2007 – Present Faculty of Medicine, National University of Malaysia, Honorary Lecturer, May 2007 – May 2009 Faculty of Medicine, Universiti Teknologi MARA, Senior Consultant Nephrologist and Head Oct 2006 – Present Department of Nephrology, Hospital Selayang, Selayang, Selangor Secretary, May 2001 – Present Postgraduate (Subspecialty) Nephrology Training Committee Ministry of Health of Malaysia Consultant Nephrologist Nov 1997 – Sept 2006 Department of Nephrology, Hospital Kuala Lumpur Chairman/Chief Editor of Advisory Board /Registry 1. Malaysian Organ Sharing System (eMOSS) 2002 till now 2. Malaysian Dialysis & Transplant Registry 2016 till now Member of Working / Steering Committee 1. National Credentialing Committee for Nephrology subspecialty 2016 – 2018 2. National Credentialing Committee for Nephrology subspecialty 2012 – 2014 3. National Transplantation Technical committee 2006 – Present 4. Ministry of Health, Malaysia, Transplantation Medicine committee 2004 – Present 5. Anaemia Working Group Asian Pacific (Malaysia Chapter) 2004 – 2006 Member of Advisory Board 1. Expert Panel of the National Transplant Registry 2015 – 2017 2. Asia Dialysis Clinical Advisory Board 2010 till now 3. Malaysian Registry of Renal Biopsy (MRRB) 2007 till now 4. National Renal Registry (NRR) 2001 till now 5. Drug control Authority, Ministry of Health, Malaysia 2001 till now Posts in Professional Bodies 1. President of the Postgraduate Renal Society of Malaysia 2016-2018 2. President of Malaysian Society of Diagnostic & Interventional

Nephrology (MSDIN) 2016-2018 3. Protem President of Malaysian Society of Diagnostic &

Interventional Nephrology (MSDIN) 2014-2016 4. Immediate Past President of Malaysian Society of Nephrology 2012-2014 5. President of Malaysian Society of Nephrology (MSN) 2010-2012 6. Vice President of Malaysian Society of Nephrology (MSN) 2008-2010 7. Chairman, eMOSS committee of NRR 2005-till now 8. Member of Board of Managers, National Kidney Foundation, M’sia 2005-2009 9. Hon. Secretary of the Postgraduate Renal Society Malaysia 2004-2016

10. Member of the MSN CME / Training committee 2002-2004 11. Committee of the HKL Renal Research Fund 2000-2004 12. Hon. Treasurer of the HKL Renal Research Fund 1998-2000 13. Hon. Secretary of the Malaysian Organ Sharing System / 1998-2000

National Renal Registry (MOSS/NRR) 14. Hon. Treasurer of the Malaysian Society of Nephrology (MSN) 1998-2000 15. Hon. Treasurer of the Malaysian Society of Nephrology (MSN) 1994-1996 Speaker at national scientific meetings 1. 4

th National Dialysis Seminar on

“The management of anaemia in ESRD:” June 1995 Kuala Lumpur, Malaysia 2. 1

st Malaysian Society of Nephrology (MSN)

Nephrology trainees symposium on “Membranous nephropathy” April 1999 Kuala Lumpur, Malaysia

3. Malaysian Dietician Society (MDS) Renal workshop for dieticians on “Key issues in HD & CAPD: Effect of nutrition” August 1999 Kuala Lumpur, Malaysia

4. MDS Renal workshop for dieticians on “Prescribing & Monitoring in dialysis” August 1999 Kuala Lumpur, Malaysia

5. Dialysis Association of Medical Assistant and Nurses (DAMAN) Optimizing Dialysis Care Workshop on “Dialysis adequacy & KT/V” May 2000 Genting Highland, M’sia

6. Pre-conference workshop (Health outcome) of the 2000 National Conference on Quality in Health on “Improving outcomes through registry” Oct 2000 Kuala Lumpur, Malaysia

7. 1st Combined Renal Transplant Course on

“Rejection: Principles of management” Oct 2000 Selayang, Selangor, M’sia 8. 17

th Malaysian Society of Nephrology (MSN)

Annual Seminar in Nephrology on “HCV infection in haemodialysis” April 2001 Johor Baru, Johor, Malaysia

9. MOSS/NRR Seminar on “Pre and Post transplant counseling” April 2001 Johor Baru, Johor, Malaysia

10. MSN Neoral C2 monitoring symposium on “HKL experience in C2 monitoring” May 2001 Kuala Lumpur, Malaysia

11. 6th Annual Scientific meeting of the Malaysian

Society of Transplantation (MST) on “HKL experience in C2 monitoring” June 2001 Selayang, Selangor, M’sia

12. 5th Annual Conf on Advances in Cardiology & Cardiovascular Therapeutics on “Diabetic Nephropathy-Latest Clinical Findings” July 2001 Kuala Lumpur, Malaysia

13. MSN Contemporary Issues in Nephrology on “Temporary vascular access & related Cx” January 2002 Kuala Lumpur, Malaysia

14. 7th Annual Scientific meeting of MST on

“C2 monitoring” April 2002 Johor Bahru, Malaysia 15. Academy of Medicine (Malaysia) Postgraduate

Course in infectious disease on “Infection in renal transplant patients” June 2002 Kuala Lumpur, Malaysia

16. 18th MSN Annual Seminar in Nephrology on

“Vascular access catheters: Anything new” July 2002 Kota Kinabalu, Sabah, M’sia 17. MSN CME program for renal care professionals

on “Hepatitis B & C in HD” Sept 2002 Selayang, Selangor, M’sia 18. Assoc of Malaysian Oral Facial Maxillary Surgeon

Course in Critically ill surgical patient on “Fluid & electrolyte” Jan 2003 Kuala Lumpur, Malaysia

19. Malaysian Urology Association’s “Basic Sciences of Urology” Block Lecture on “Renal function” March 2003 Kuala Lumpur, Malaysia

20. 19th MSN Annual Seminar in Nephrology on

Monitoring of vascular access May 2003 Kuantan, Pahang, Malaysia

21. 2nd National Kidney Foundation (NKF) Annual Dialysis meeting on “Advances in HD machines” March 2004 Kuala Lumpur, Malaysia

22. 8th Annual Scientific meeting of MST

on “MOSS Waiting List” August 2004 Penang, Malaysia 23. 3

rd National Seminar on Medical Disorder in

pregnancy on “Mx of renal disease in pregnancy” Sept 2004 Kuala Lumpur, Malaysia 24. Malaysian Pharmaceutical Society (MPS)’s

Updates on Transplant” on “Outcome of Transplant Therapy” June 2005 Kota Kinabalu, Sabah, M’sia

25. 6th MOH-AMM Scientific meeting on

“Immunosuppression-balancing benefits & risk” Sept 2005 Kuala Lumpur, Malaysia 26. UKM Nephropathies in Systemic Dis workshop on “Diabetes nephropathy:Mx strategies Feb 2006 Kuala Lumpur, Malaysia 27. 22rd MSN Annual Seminar in Nephrology on

“NRR 2005 highlights: Dialysis survival” April 2006 Kuala Lumpur, Malaysia 28. 7

th ADMAN Annual meeting on “ Reducing

Catheter related infection: What is new? August 2006 Kuala Lumpur, Malaysia 29. 7

th ADMAN Annual meeting on “ Key

performance indicators in nephrology August 2006 Kuala Lumpur, Malaysia 30. Festschrift in honour of Dato’ Dr Zaki Morad on

“ Transplantation: Small but significant steps” Sept 2006 Kuala Lumpur, Malaysia 31. 4

th Annual NKF Dialysis Meeting on

“Vascular access surveillance” Sept 2006 Penang, Malaysia 32. 1

st Diagnostic & Interventional Nephrology (DIN)

meeting on “Why must nephrologists do ultrasound” Jan 2007 Kuala Lumpur, Malaysia

33. 23rd MSN Annual Seminar in Nephrology on NRR 2006 highlights: “Dialysis survival” May 2007 Johor Bahru, Johor, M’sia

34. Quality in Dialysis Conference on “Vascular access surveillance” June 2007 Kuala Lumpur, Malaysia

35. 10th Annual Scientific meeting of MST on “Perioperative care of renal Tx recipient” July 2007 Kuala Lumpur, Malaysia

36. 8th ADMAN Annual meeting on “Cardiovascular

risk factors reduction in dialysis patients” July 2007 Pahang, Malaysia 37. 5

th NKF Annual Dialysis Meeting on “ CPGs in

vascular access” Nov 2007 Kuala Lumpur, Malaysia 38. PD college 2008 on “ Expanding the PD unit: How

to be successful” July 2008 Kuala Lumpur, Malaysia 39. 2

nd Annual DIN meeting on “Catheter related

infection: What is new” August 2008 Kuala Lumpur, Malaysia 40. 2

nd Annual DIN meeting on “Vascular access

monitoring” August 2008 Kuala Lumpur, Malaysia 41. MST Nephrology Transplant course 2008 on

“IL2 antibodies” Dec 2008 Kuala Lumpur, Malaysia 42. MST Nephrology Transplant course 2008 on

“PSI” Dec 2008 Kuala Lumpur, Malaysia 43. 25

th MSN Annual Seminar in Nephrology on

“PSI: Is this the way forward” April 2009 Johor Bahru, Johor, M’sia 44. 25


“Optimising MPA therapy” April 2009 Johor Bahru, Johor, M’sia 45. MST Nephrology Transplant course 2009 on

“ Polyoma virus nephropathy” June 2009 Kuala Lumpur, Malaysia 46. 1

st National Scientific meeting of renal pharmacy on

“Individualization of Immunosuppression” July 2009 Kuala Lumpur, Malaysia 47. 12

th Scientific meeting of MSTx on

“New development in organ allocation” August 2009 Melaka, Malaysia 48. MSN Haemodialfitration Symposium on “HDF:

Implementation & Practical Issues” August 2009 Kuala Lumpur, Malaysia 49. 10

th ADMAN Annual meeting on “Management

of intradialytic hypotension” Nov 2009 Melaka, Malaysia

50. 3rd

Annual DIN meeting on “DIN: What the future hold” Dec 2009 Kuala Lumpur, Malaysia

51. 3rd

Annual DIN meeting on “USG of native kidneys” Dec 2009 Kuala Lumpur, Malaysia

52. 3rd

Annual DIN meeting on “Renal biopsy: From KUB to intravenous” Dec 2009 Kuala Lumpur, Malaysia

53. 7th NKF Annual Dialysis Meeting on “ Vascular

access monitoring” Dec 2009 Kuala Lumpur, Malaysia 54. 7

th NKF Annual Dialysis Meeting on “ Role of

Vitamin D in hyperparathyroidism” Dec 2009 Kuala Lumpur, Malaysia 55. Malaysian Society of Haematology 2

nd Myeloma

workshop on ”Myeloma kidney disease” March 2010 Kuala Lumpur, Malaysia 56. 9

th Weekend Seminar Series in Cardiology on

“Prevention of hypertensive nephropathy” March 2010 Kuala Lumpur, Malaysia 57. 26


NRR 2009 highlights: “Dialysis survival” April 2010 Kuching, Sarawak, M’sia 58. 26


MRRB 2008 highlights: “Renal allograft biopsy” April 2010 Kuching, Sarawak, M’sia 59. 26

h MSN Annual Seminar in Nephrology on

“USG in nephrology: What is in the horizon” April 2010 Kuching, Sarawak 60. MSN Seminar in Transplantation on “Pre

transplant workup & time zero biopsy” May 2010 Kuala Lumpur, Malaysia 61. 13

th Scientific meeting of MSTx on

“CNI sparing regimen” July 2010 Kuala Lumpur, Malaysia 62. Postgraduate Renal Society Malaysia (PGRSM)’s

course in CRRT &GN on “Management of resistant lupus nephritis” Oct 2010 Kuala Lumpur, Malaysia

63. MPS Pre-conference renal pharmacy workshop on “Optimising MPA therapy” Oct 2010 Kuala Lumpur, Malaysia

64. 19th Malaysian Urological Conference on

on “Ultrasound in vascular access” Nov 2010 Kuching, Sarawak, M’sia 65. 4

th Annual DIN meeting on “HD catheters : Past,

Present & Future” Dec 2010 Selayang, Malaysia 66. 4

th Annual DIN meeting on “USG in vascular

accesss :Mastering the art, Dec 2010 Selayang, Malaysia 67. 27

th Annual Congress of the MSN on “NRR

2010 highlights: Dialysis survival” May 2011 Kuala Lumpur, Malaysia 68. 27

th Annual Congress of the MSN on “MRRB

2009 highlights: “Renal allograft biopsy” May 2011 Kuala Lumpur, Malaysia 69. 27

th Annual Congress of the MSN on “TDM in

transplantation: Learning the secret” May 2011 Kuala Lumpur, Malaysia 70. 14

th Scientific Meeting of MST on “Updates in

recent clinical trials” June 2011 Penang, Malaysia 71. 14

th Scientific Meeting of MST on “TDM in

transplantation: Learning the secret” June 2011 Penang, Malaysia 72. PGRSM Update in CKD on “RAAS in the kidney:

A paradigm shift in therapeutic target” Oct 2011 Kuala Lumpur, Malaysia 73. 9

th NKF Annual Dialysis Meeting on “ Dialyser

Membranes: one shoe fit all” Nov 2011 Kuala Lumpur, Malaysia 74. Weekend Seminar in Cardiology 2012 on “ Is there

a J curve in salt intake in hypertensive patients” Feb 2012 Kuala Lumpur, Malaysia 75. 5

th Quality in Dialysis Conference on “The ideal

dialysis:A renal physician’s perspective” Mar 2012 Sepang, Selangor, Malaysia 76. 14

th Scientific Meeting of MST on “MPA in

Renal Tx: Past, Present & Future” May 2012 Kuching, Sarawak, M’sia 77. 12

th ADMAN Annual Dialysis Seminar on “HD

Rx outcome in Malaysia:Where are we now” June 2012 Kuantan, Pahang, Malaysia 78. NRR Annual meeting 2012 on “ Dialysis

Survival” July 2012 Kuala Lumpur 79. 10

th NKF Annual Dialysis Meeting on “Vascular

access: Current trend & moving forward” Oct 2012 Kuala Lumpur, Malaysia 80. 4

th HKL Ambulatory Care Pharmacy Conference

on “PSI: Past, Present & Future” Dec 2012 Kuala Lumpur, Malaysia 81. 6

th Annual DIN meeting on on “Choosing HD

catheter: Doing it right” Dec 2012 Selangor, Malaysia 82. 6

th Annual DIN meeting on “Dealing with catheter

assoc complications” Dec 2012 Selangor, Malaysia 83. 6

th Annual DIN meeting on “Improving PD

uptake: Can it be done” Dec 2012 Selangor, Malaysia 84. 29

th Annual Congress of the MSN on “Managing a

failing renal allograft:What to consider” June 2013 Johor Baru, Johor, Malaysia 85. Advisory Board Meeting on Telbivudine impact on

renal function of chronic hepatitis B patients on “Monitoring renal function in clinical practice” Sept 2013 Kuala Lumpur, Malaysia

86. PGRSM Update in HD on “Landmarks studies” Sept 2013 Kuala Lumpur, Malaysia 87. 13

th ADMAN Annual Dialysis Seminar on “HD Rx

outcome in M’sia: Is there room for improvement” Nov 2013 Melaka, Malaysia 88. 7

th Annual DIN Meeting on “Choosing the right

HD catheter” Nov 2013 Selangor, Malaysia 89. 7

th Annual DIN meeting on “Difficult catheter

insertion: Tips & Tricks” Nov 2013 Selangor, Malaysia 90. 7

th Annual DIN meeting on “Recurrent catheter

malfunction: Avoiding the pit fall” Nov 2013 Selangor, Malaysia 91. 7

th Annual DIN meeting on “USG in nephrology” Nov 2013 Selangor, Malaysia

92. 11th Annual Scientific Meeting of Malaysian

Society of Hypertension (MSH) on ”Hypertension in CKD patient” Jan 2014 Kuala Lumpur, Malaysia

93. 17th Scientific Meeting of MST on “Approach in

Personalizing maintenance immunosuppression” May 2014 Kuala Lumpur, Malaysia 94. 17

th Scientific Meeting of MST on “MPA in

Transplantation: Mastering the Art” May 2014 Kuala Lumpur, Malaysia 95. 30

th Annual Congress of the MSN on “MRRB

2012 highlights: Renal allograft biopsy” June 2014 Kuala Lumpur, Malaysia 96. PGRSM 2014 Update in Peritoneal dialysis on

“Update in PD trials” Oct 2014 Kuala Lumpur, Malaysia 97. 14

th ADMAN Annual Dialysis Seminar on

“Technological advancements in the design of dialysis cathetersfor better performance” Nov 2014 Kuantan, Malaysia

98. 8th Annual DIN meeting on “Choosing the

right cuffed HD catheter” Dec 2014 Selangor, Malaysia 99. 12

th Annual Scientific Meeting of MSH on

”Relevance of RAS in Hypertension Mx” Jan 2015 Kuala Lumpur, Malaysia 100. Malaysia Society of Gastroenterology &

Hepatology (MSGH) Update on “Importance of renal protection among HBV patients” Feb 2015 Kuantan, Malaysia

101. 7th Diabetes Complications Conference & Grand

Rounds 2015 on “Kidney & Diabetes” March 2015 Kuala Lumpur, Malaysia 102. NRR Annual meeting 2015 on “eMOSS : Issues

& challenges” Dec 2015 Putrajaya, Malaysia 103. 32

nd Annual Congress of the MSN on “Current

evidence in benefit of Home HD” April 2016 Johor Baru, Johor, Malaysia 104. 19

th Scientific Meeting of MST on “Post

transplant malignancy:Can we mitigate the risk? May 2016 Kuala Lumpur, Malaysia 105. 19

th Scientific Meeting of MST on “Transplant

immunosuppression: Is there anything else after KDIGO guidelines?” May 2016 Kuala Lumpur, Malaysia

106. PGRSM 2016 Update in CKD & HD on “Current perspective on hyperuricaemia & kidney” Sept 2016 Kuala Lumpur, Malaysia

107. PGRSM 2016 Update in CKD & HD on “Dialysis dose and outcome” Sept 2016 Kuala Lumpur, Malaysia

108. 15th ADMAN Annual Dialysis Seminar on

“Lipid management in CKD” Sept 2016 Melaka, Malaysia 109. 13

th NKF Annual Dialysis Meeting on “Home

HD: What are the challenges?” Nov 2016 Kuala Lumpur, Malaysia 110. 10

th Annual DIN meeting on “Choosing the

right non cuffed HD catheter” Nov 2016 Putrajaya, Malaysia 111. 10

th Annual DIN meeting on “Controversies in

vascular access surveillance” Nov 2016 Putrajaya, Malaysia 112. MSN Transplant immunology short course 2017 on

“ Immunosuppression: Action, efficacy & AE” Mar 2017 Kuala Lumpur, Malaysia 113. PGRSM update: PD college 2017 on “PD in

Malaysia: Past, Present & Future” April 2017 Kuala Lumpur 114. 9

th Diabetes Complications Conference & Grand

Rounds 2017 on “Early nephropathy: Clinical April 2017 Kuala Lumpur, assessment and laboratory markers”

115. 20th Scientific Meeting of MST on “eMOSS: How

to improve kidney allocation: Should we revisit” May 2017 Melaka, Malaysia, 116.

Speaker at international scientific meetings 1. 2nd Prograf Asia/Oceania Workshop on

“Risk factors for cardiovascular disease” June 2002 Sapporo, Hokkaido, Japan 2. Novartis Transplantation Asian Forum on “C2

monitoring and adsorption profile of cyclosporin microemulsion in renal transplant recipients” Sept 2003 Kuala Lumpur, Malaysia

3. Asia Pacific Society of Nephrology’s course on Kidney failure & dialysis on “Vascular access

4. monitoring: Is it worth it?” Oct 2004 Kuala Lumpur, Malaysia 5. Regional expert meeting on SLE and

Transplantation on “ Advances in Lupus nephritis Management” April 2005 Ho Chi Minh, Vietnam

6. 3rd

World Congress in Nephrology post congress satellite ARF symposium on “Anticoagulation in CRRT” July 2005 Penang, Malaysia

7. 1st Regional expert meeting on renal anaemia,

Transplantation and SLE on “CNI sparing regimens: An update” June 2006 Siem Reap, Cambodia

8. 2nd

Regional meeting on Transplant, SLE and Renal anaemia on “Striking a balance in efficacy & toxicities in renal transplant patients” April 2007 Yangon, Myanmar

9. Asia Transplant & Immunology Forum 2007 on “ Renal Transplantation in Malaysia: What we have achieved so far” Nov 2007 Kuala Lumpur, Malaysia

10. PSI academy 2008 on “Introducing PSI in transplantation” April 2008 Kuala Lumpur, Malaysia

11. 11th Asian Pacific Congress of Nephrology on

“Ultrasonography for Nephrologists” May 2008 Kuala Lumpur, Malaysia 12. 3

rd Regional Expert Forum on Liver &

Kidney on “Individualising immunosuppression” June 2008 Hanoi, Vietnam 13. Kuala Lumpur Vascular Access Conference 2010

on “Surveillance of vascular access” March 2010 Kuala Lumpur, Malaysia 14. 11

th IFKF International meeting on “Mastering the

art of using vitamin D” May 2010 Kuala Lumpur, Malaysia 15. 5

th Regional Expert Forum on Anaemia, virology

& transplant on “Optimising MPA therapy for better graft outcome” May 2010 Phnom Penh, Cambodia

16. Asia Dialysis Clinical Advisory Board Meeting

on “Catheter insertion site: When preferred sites are not available” Sept 2010 Shanghai, China

17. Myanmar Medical Association Annual meeting on “MMF in Transplantation: Past, Present & Future” Jan 2012 Yangon, Myanmar

18. 3rd

Asia Dialysis Expert Meeting on “ HD catheter access: Site selection, Techniques & Pit fall April 2013 Taipei, Taiwan

19. Taiwan Society of Nephrology Access Forum on “Dealing with difficult HD catheter access” April 2013 Taipei, Taiwan

20. Asia Cluster Transplantation Summit on “Paradigm shift in Kidney transplantation” Sept 2013 Manila, Philippines

21. Asia Cluster Transplantation Summit on “The PROGIS results” Sept 2013 Manila, Philippines

22. 7th Indonesia Nephrology Forum on “ Role of

Interventional Nephrology in Vascular Access” May 2014 Jakarta, Indonesia 23. 14

th Jakarta Nephrology & Hypertension Course

on “State of the Art: Interventional Nephrology” May 2014 Jakarta, Indonesia 24. Kuala Lumpur Vascular Access Conference 2014

on “When permanent access is not possible: Alternative strategies” Oct 2014 Kuala Lumpur, Malaysia

25. Dialysis Access Symposium 2015 on “Current state of vascular access management in Malaysia” Aug 2015 Seoul , Korea

26. Dialysis Access Symposium 2015 on “Controversies in Vascular Access Surveillance” Aug 2015 Seoul , Korea

27. 14th Congress of the Asian Society of Tx on (CAST)

on “Lipid & CV Risk Management in Solid Organ Transplant” Aug 2015 Singapore

28. 9th Congress of the International Society of HD on

“Choosing the right HD catheter” Sept 2015 Kuala Lumpur, Malaysia 29. 9

th Congress of the International Society of HD on

“Improving outcome in cuffed catheter insertion” Sept 2015 Kuala Lumpur, Malaysia 30. 36

th Annual Meeting of the Korean Society of

Nephrology on “Dealing with difficult HD catheter” June 2016 Seoul, Korea 31. 11

th Congress of the International Society of HD on

“Benefit of vascular surveillance” Aug 2017 Bangkok, Thailand 32. 13

th Asian Congress of Pediatric Nephrology

“Vascular access: Fistula vs catheter” Oct 2017 Kuala Lumpur, Malaysia 33. Dialysis Access Symposium 2017 on “Dialysis

access in Malaysia” Oct 2017 Nagoya, Japan 34.

Oral / Poster Research Presentations at national scientific meeting 1. Hyponatraemia in pulmonary tuberculosis. Wong HS, Cheong I. 4

th UKM Medical colloquium, 18-

19th August 1995. Kuala Lumpur

2. Case Report: Cytomegalovirus induced gastric ulceration with gastrointestinal bleeding. Bavanandan S, Ganesananthan S, Wong HS, Kew ST, Morad Z et al. GUT 2000, Malacca, Malaysia.

3. Plug renal biopsy: A preliminary report. Wong HS, Zaki M. 17th Annual Seminar in Nephrology. 20-

22nd

April 2001, Johor Bahru, Malaysia. 4. Nutritional assessment of continuous ambulatory peritoneal dialysis patients in Hospital Kuala

Lumpur. Yahya R, Ismail L, Tan PC, Wong HS, Goh BL, Zaki M. 17th Annual Seminar in

Nephrology. 20-22nd

April 2001, Johor Bahru, Malaysia. 5. Prevalence of hepatitis C in haemodialysis patients. Mukhatar I, Ramli S, Wong HS, Zaki M. 17

th

Annual Seminar in Nephrology. 20-22nd

April 2001, Johor Bahru, Malaysia. 6. Exercise programme for haemodialysis patients: A preliminary assesment. Wong CC, Wong HS,

Zaki M. 17th Annual Seminar in Nephrology. 20-22

nd April 2001, Johor Bahru, Malaysia.

7. Desferrioxamine treatment in aluminum toxicity among hameodialysis patients: A single centre experience. Mah SS, Wong HS, Zaki M. 17

th Annual Seminar in Nephrology. 20-22

nd April 2001,

Johor Bahru, Malaysia.

8. Factors associated with delay in permanent access creation in pre-ESRD patients. CH Ching, HS Wong, Z Morad. 18


th July 2002, Kota Kinabalu, Malaysia

9. Significant bacteriuria in new renal transplant recipients. Mohd Ramli S, Wong HS, Zaki M. 18th

Annual Seminar in Nephrology. 25-28th July 2002, Kota Kinabalu, Malaysia

10. Safety and efficacy of intravenous iron supplement (iron dextran) in patients on continuous ambulatory peritoneal dialysis. Tan PC, Wong HS, Zaki M. 18

th Annual Seminar in Nephrology. 25-

28th July 2002, Kota Kinabalu, Malaysia

11. Aggressive calcium replacement regimen in preventing hungry bone syndrome post parathyroidectomy. A single center experience. Anthony V, Wong HS, Zaki Morad. 18

th Annual

Seminar in Nephrology. 25-28th July 2002, Kota Kinabalu, Malaysia

12. Prevalence of under delivery of dialysis and access recirculation in haemodialysis patients. C. Lazar, H.S.Wong, H.F.Marcos, A. Nasir, T.S.Singam, Z Morad. 18

th Annual Seminar in Nephrology.

25-28th July 2002, Kota Kinabalu, Malaysia

13. Fungal Peritonitis in Continuous Ambulatory Peritonitis Dialysis (CAPD) Patients: A Single Center Experience. BY How, PC Tan, HS Wong, Z Morad. 18


th

July 2002, Kota Kinabalu, Malaysia 14. Characteristic of patients receiving temporary intermittent haemodialysis in a hospital based

haemodialysis unit. A single center experience. CC Wong, HS Wong, Zaki M. 18th Annual Seminar

in Nephrology. 25-28th July 2002, Kota Kinabalu, Malaysia

15. Evaluation of the effective blood flow and recirculation in temporary haemodialysis catheter when the arterial and venous lumens are reversed. A.Suhaili, HS Wong, Z Morad. 18

th Annual Seminar in

Nephrology. 25-28th July 2002, Kota Kinabalu, Malaysia

16. Safety and efficacy of intravenous iron supplement (iron dextran) in patients on continuous ambulatory peritoneal dialysis. Tan PC, Wong HS, Zaki M. 18

th Annual Seminar in Nephrology. 25-

28th July 2002, Kota Kinabalu, Malaysia

17. Fungal Peritonitis in Continuous Ambulatory Peritonitis Dialysis (CAPD) Patients: A Single Center Experience. How, PC Tan, HS Wong, Z Morad. 18


th July

2002, Kota Kinabalu, Malaysia 18. Comparison of patient survival between haemodialysis and CAPD in diabetic patients: A single

center experience. Shahnaz SFK, Wong HS, Zaki Morad. 19th Annual Seminar in Nephrology. 2-4

th

May 2003, Kuantan, Pahang, Malaysia 19. Patient and technique survival in diabetic and non diabetic patients on CAPD: A single center

experience. Shahnaz SFK, Wong HS, Zaki Morad. 19th Annual Seminar in Nephrology. 2-4

th May

2003, Kuantan, Pahang, Malaysia 20. Factors associated with peritoneal transport characteristics in CAPD patients. Ching CH, Wong

HS, Zaki Morad. 19th Annual Seminar in Nephrology. 2-4

th May 2003, Kuantan, Pahang, Malaysia

21. Intra access flow in haemodialysis patients. Suhaili S, Wong HS, Zaki Morad. 19th Annual Seminar

in Nephrology. 2-4th May 2003, Kuantan, Pahang, Malaysia

22. Realtime ultrasonographic assisted insertion of haemodialysis catheters. A single center experience. Noraziah A, Wong HS, Zaki Morad. 19


th May

2003, Kuantan, Pahang, Malaysia 23. Review of patients on longstanding continuous ambulatory peritoneal dialysis in Hospital Kuala

Lumpur. Vijaya L, Ching CH, Wong HS, Zaki Morad. 19th Annual Seminar in Nephrology. 2-4

th May

2003, Kuantan, Pahang, Malaysia 24. Factors associated with peritonitis in continuous ambulatory peritoneal dialysis patients. Laizah I,

Ching CH, Wong HS, Zaki Morad. 19th Annual Seminar in Nephrology. 2-4

th May 2003, Kuantan,

Pahang, Malaysia 25. Effect of conversion of subcutaneous EPO to intravenous EPO on haemoglobin concentration: HKL

experience. Norlida O, Wong HS, Zaki Morad. 19th Annual Seminar in Nephrology. 2-4

th May 2003,

Kuantan, Pahang, Malaysia 26. Comparison of high flux haemodialysis and haemodialfiltration in the treatment of aluminium

overload in haemodialysis population. Mah SS, Wong HS, Ong KL, Goh KW. 20th MSN Annual

Seminar in Nephrology. 7-9th May 2004, Kuching, Sarawak, Malaysia.

27. Significance of various modalities in assessment of donor renal function in predicting post nephrectomy serum creatinine. Kuan-Weng Go, Hin-Seng Wong, Zaki Morad. 20

th MSN Annual

Seminar in Nephrology. 7-9th May 2004, Kuching, Sarawak, Malaysia.

28. Comparison between total parathyroidectomy with autotransplantation and without autotransplantation in treatment of tertiary hyperparathyroidism. Kuan-Weng Go, Hin-Seng Wong, Zaki Morad. 20

th MSN Annual Seminar in Nephrology. 7-9

th May 2004, Kuching, Sarawak,

Malaysia.

29. Management of renal bone disease in accordance to NKF K/DOQI guideline: A single centre experience. Thian-Fook Chew, Hin-Seng Wong, Zaki Morad. 20

th MSN Annual Seminar in

Nephrology. 7-9th May 2004, Kuching, Sarawak, Malaysia.

30. Predictors opf clinical outcome with bioimpedance analysis in CAPD patients. Keng-Hee Koh, Hin-Seng Wong, Kuan-Weng Go, Hin-Seng Wong, Zaki Morad. 22


Nephrology. 28-30th April 2006, Kuala Lumpur, Malaysia.

31. The impact of concomitant membranous lupus nephritis on the outcome of proliferative lupus nephritis. N.D. Baskaran, H.S. Wong, B.C.Bee, A. Rafidah, K.S. Gan. 23

rd MSN Annual Seminar in

Nephrology. 11-13th May 2007, Johor, Malaysia.

32. Peritoneal Dialysis: A comparison between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis. Noriah Mat, Hin-Seng Wong, Boon-Cheak Bee, Rafidah Abdullah. 23

rd MSN Annual Seminar in Nephrology. 11-13

th May 2007, Johor, Malaysia.

33. Outcomes of tunneled translumbar inferior vena cava hemodialysis catheter: A comparison study. K.S.Gan, H.S.Wong, B.C.Bee, A. Ghazali, A. Rafidah, H.W.Lee, N.D.Baskaran, M.H. Shahrina, M. Sobri. 23

rd MSN Annual Seminar in Nephrology. 11-13

th May 2007, Johor, Malaysia.

34. Automated Peritoneal Dialysis versus Chronic Ambulatory Peritoneal Dialysis: any difference in clinical effectiveness? Noriah M, Eddie WFS, Rafidah A, Bee BC, Wong HS. 26

th MSN Annual

Seminar in Nephrology. 23-25th April 2010, Kuching, Sarawak, Malaysia

35. Peritoneal Dialysis analysis of mortality biochemical risk factors: 10-year experience of Selayang Hospital. Noriah M, Eddie WFS, Rafidah A, Bee BC, Wong HS. 26


Nephrology. 23-25th April 2010, Kuching, Sarawak, Malaysia

36. Duration of deranged coagulation profile to normalise after heparin free dialysis with heparin lock: an observational study. HK Goh, Suryati Y,Rafidah A, BC Bee, HS Wong. 26

th MSN Annual


37. Effectiveness of low dose tacrolimus with high dose mycophenolate acid in renal transplantation. A single centre experience. Suryati Y, Goh HK, Rafidah A, Bee BC, Wong HS. 26

th MSN Annual


38. Predictor survival factors in elderly renal failure patients treated with peritoneal dialysis: a ten-year retrospective study. Suryati Y, Goh HK, Norhaslinda M, Aina NA, Rafidah A, Bee BC, Wong HS. 26


th April 2010, Kuching, Sarawak, Malaysia

39. Prevalence of asymptomatic proteinuria during World Kidney Day screening: has it improved over the years? Eddie WFS, Norhaslinda M, Jasman A, Aniza H, Rafidah A, Wong HS. 26

th MSN

Annual Seminar in Nephrology. 23-25th April 2010, Kuching, Sarawak, Malaysia

40. Safety of Antiplatelet Therapy on Peritoneal Access Surgery. HK Goh, KX Yip, Suryati Y, Rafidah A, BC Bee, HS Wong. 26


th April 2010, Kuching,

Sarawak, Malaysia 41. Medication reconciliation and discrepancies on admission among nephrology patients. Ismail MG,

Ibrahim N, Othman F, Hin Seng W, Chia Kee L, Mokhta MH, Zulkifli NZ. 26th MSN Annual Seminar

in Nephrology. 23-25th April 2010, Kuching, Sarawak, Malaysia

42. A randomised controlled trial comparing safety and efficacy of citrate locking solution compared to heparin in patients undergoing heparin free dialysis. HK Goh, Aina A.N, Suryati Y, Rafidah A, BC Bee, HS Wong. 26


th April 2010, Kuching, Sarawak,

Malaysia 43. A pharmacokinetic study on the optimal dosing of mycophenolic acid in stable renal transplant

recipients on tacrolimus based and cyclosporine A based regimen. Suryati Yakob, Hin-Seng Wong, Heong-Keong Goh, Rafidah Abdullah, Boon-Cheak Bee. 13

th Scientific meeting of MSTx. 8-

10th July 2010, Kuala Lumpur

44. A pharmacokinetic study on the Impact of calcineurin inhibitors on mycophenolic acid trough level. Heong-Keong Goh, Hin-Seng Wong, Rafidah Abdullah, Suryati Yakob, Boon-Cheak Bee. 13

th

Scientific meeting of MSTx. 8-10th July 2010, Kuala Lumpur

45. HEparin LOcking solution in maintaining CAtheter Patency study: A prospective, randomized, controlled, open labeled study on efficacy of the different concentration of heparin locking solution (The HELOCAP study). Eddie WFS, Aina N, Chew J, Yim YG, Moggie Y , Mohd Farid S, Suryati Y, Esther TZZ, Rafidah A, Bee BC, Goh CY, Wong HS. 27

th Annual Congress of Malaysian Society of

Nephrology. 6-8th May 2011, Kuala Lumpur

46. Low Calcium Dialysate: does it affect QTc? Esther TZZ, Faizah H, Zarina A, Zulhelmi A, Rafidah A, Wong HS. 27

th Annual Congress of Malaysian Society of Nephrology. 6-8

th May 2011, Kuala

Lumpur

47. Exhausted vascular access: Translumbar or Transhepatic catheter? Saravanan K, Murbita S, Mohd Rizal R, Rafidah A, Wong HS. 27


th May

2011, Kuala Lumpur 48. Risk factors for proteinuria in HIV seropositive patients in Malaysia. Esther TZZ, Eddie WFS,

Suryati Y, Rafidah A, Benedict S, Wong HS, Christopher Lee. 27th Annual Congress of Malaysian

Society of Nephrology. 6-8th May 2011, Kuala Lumpur

49. Direction of arterial needle direction in arteriovenous fistula: Does it affect dialysis adequacy? Jasman AM, Mohd Nizam I, Sarudin Z, Balasundram B, Rafidah A, Wong HS. 27

th

Annual Congress of Malaysian Society of Nephrology. 6-8th

May 2011, Kuala Lumpur (1st

prize for paramedic category)

50. The effectiveness and safety of the visual assisting device in peritoneal dialysis patients with impaired vision. A single centre experience. Noriah M, Rozeta I, Zahariah Z Saripah S, Goh CY, Wong HS, Bee BC, Rafidah A. 27


th

May 2011, Kuala Lumpur 51. Peritonitis and its risk factors in geriatric patients on peritoneal dialysis. Suryati Y, Wong HS,

Noriah M, Wong EFS, Rafidah A, Goh CY, Bee BC. 27th Annual Congress of Malaysian Society of

Nephrology. 6-8th May 2011, Kuala Lumpur

52. Survival in geriatric patients on peritoneal dialysis. Suryati Y, Wong HS, Noriah M, Wong EFS, Rafidah A, Goh CY, Bee BC. 27


th May

2011, Kuala Lumpur 53. Low Calcium Dialysate: does it affect QTc? Esther TZZ, Faizah H, Zarina A, Zulhelmi A, Rafidah A,

Wong HS. 27th Annual Congress of Malaysian Society of Nephrology. 6-8

th May 2011, Kuala

Lumpur 54. The effectiveness and safety of an innovative group training programme for end stage renal failure

patients starting peritoneal dialysis. Noriah M, Rozeta I, Zahariah Z, Saripah S, Goh CY, Wong HS, Bee BC, Rafidah A. 27


th May 2011,

Kuala Lumpur 55. Hand pain in haemodialysis patients: How common is it? Muhaini CM, Aniza HS, Rafidah A, Wong

HS. 27th Annual Congress of Malaysian Society of Nephrology. 6-8

th May 2011, Kuala Lumpur

56. Access trend at initiation of dialysis: Has there been any change? Ruslaili M, Hakima M, Lai YY, Eddie WFS, Rafidah A, Wong HS. 27


th

May 2011, Kuala Lumpur 57. Insertion of noncuffed double lumen internal jugular catheter: Safe without fluoroscopy? Sarifah

Bakar, Haspizaila Hashim, Rosmiza Hassan, Rafidah Abdullah, Wong Hin Seng. 27th Annual

Congress of Malaysian Society of Nephrology. 6-8th May 2011, Kuala Lumpur

58. Type & factors contributing to medication discrepancies in haemodialysis unit. Choong CL, Ibrahim N, Othman A, Wong HS, Lee YC, Jamaludin H, Omar M, Abdullah MA, Abidin NZ, Osman RA. 27

th

Annual Congress of Malaysian Society of Nephrology. 6-8th May 2011, Kuala Lumpur

59. Impact of diltiazem on everolimus pharmacokinetics in renal transplant recipients: A multicente study. Suryati Y, Esther TZZ, Rafidah A, Wong HS, Goh CY, Bee BC, Wan Ahmad Hafiz WAD, Lim Sk. 14

th Scientific meeting of MSTx. 2-5

th June 2011, Penang

60. Retrospective analysis of the safety and effectiveness of replacing a calcineurin inhibitor with everolimus in renal transplant recipients. Esther TZZ, Suryati Y, Rafidah A, Wong HS, Goh CY, Bee BC. 14

th Scientific meeting of MSTx. 2-5

th June 2011, Penang

61. Incidence and severity of new onset proteinuria after conversion to everolimus in renal transplant recipients. A Single Centre’s Experience. Fariz Safhan MN, Wong HS, Abdullah R, Bee BC, Goh CY, Esther TZZ, Ramasamy C. 15

th Scientific meeting of Malaysian Society of Transplantation, 17-

19th May 2012, Kuching

62. Steroid Free Regime in Living Related Renal Transplantation. Is it safe? Tan EZZ, Wong HS, Rafidah A, Goh CY, Bee BC, Fariz Safhan MN, Sadanah AM. 15

th Scientific meeting of Malaysian

Society of Transplantation. 17-19th May 2012, Kuching

63. Lack of Organ Donation: where did we go wrong? Wan Mohd Rasis W.A.K, Sharifah Sarah SMA, Rafidah A, Fariz Safhan MN, Hin-Seng Wong, Azizul KMN, Mohd Azrul S, Muhamad Ali AK, Hirman I. 15

th Scientific meeting of Malaysian Society of Transplantation. 17-19

th May 2012,

Kuching 64. Potential living kidney donor: factors leading to nontransplantation – A Single Centre’s

Experience. Chitra Ramasamy, Rafidah A, Wong HS, Goh CY, Bee BC. 15th

Scientific meeting of Malaysian Society of Transplantation. 17-19

th May 2012, Kuching. (1

st prize for paramedic

category)

http://www.ncbi.nlm.nih.gov/pubmed/18793564

http://www.ncbi.nlm.nih.gov/pubmed/18793564

65. Infection in the immediate and early post renal transplant period: Can we do anything? Lai YY, Wong HS, Rafidah A, Goh CY, Bee BC, Malek R, Tan EZZ, Fariz Safhan MN. 15

th Scientific

meeting of Malaysian Society of Transplantation. 17-19th

May 2012, Kuching. (2nd

prize for paramedic category)

66. Impact of renal donors on immediate post renal transplant care: A single centre experience. Lai YY, Wong HS, Rafidah A, Goh CY, Bee BC, Malek R, Tan EZZ, Fariz Safhan MN. 15

th Scientific

meeting of Malaysian Society of Transplantation. 17-19th May 2012, Kuching

67. Is Early Steroid Withdrawal in Renal Transplantation safe for Malaysians ? Eason Chang, Wong HS, Bee BC, Goh CY, Suryati Y. 16

th Scientific meeting of Malaysian Society of

Transplantation. 2-4th

May 2013, Kuantan (3rd

prize for doctor category) 68. What are the predictors of mortality in patients who return to dialysis after a failed transplant? Lee

J, Wong HS, Suryati Y, Goh CY, Bee BC. 29th

Annual Congress of Malaysian Society of Nephrology. 21-23

rd June 2013, Johor Baru.

69. Impact of dialysis modality on patient outcome after failed renal transplantation. Lee Jun, Wong HS, Suryati Y, Goh CY, Bee BC. 29

th Annual Congress of Malaysian Society of

Nephrology. 21-23rd

June 2013, Johor Baru. (4th

prize for doctor category) 70. Three Cases of Pleural Effusion secondary to Pleuroperitoneal Fistula in Peritoneal Dialysis

Patients. Lee J, Wong HS, Suryati Y, Goh CY, Bee BC. 29th Annual Congress of Malaysian Society

of Nephrology. 21-23rd

June 2013, Johor Baru. 71. Self-administered Intra-peritoneal Antibiotics for Bacterial Peritonitis in Peritoneal Dialysis Patients.

Lee J, Wong HS, Suryati Y, Goh CY, Bee BC. 29th Annual Congress of Malaysian Society of

Nephrology. 21-23rd

Jun 2013, Johor Baru. 72. Comparison study on the safety & outcome of right external jugular cuffed hemodialysis

catheter compared to the conventional right internal jugular cuffed hemodialysis catheter. MK Ahmad, Hin-Seng Wong, Rafidah Abdullah, Suryati Yakob, Ching-Yan Goh, Boon-Cheak Bee. 29


rd June 2013, Johor

Baru. (5th

prize for doctor category) 73. Pilot study on food wastage in haemodialysis unit Hospital Selayang. Teong LF, Wong HS, Suryati

Y, Mageswary L, Lee TL. 30th Annual Congress of Malaysian Society of Nephrology. 20-22

nd Jun

2014, Kuala Lumpur. 74. A prospective cross-over study on comparison between citrate and acetate based dialysate in

bicarbonate haemodialysis among chronic haemodialysis patients. MK Ahmad, Suryati Y, Wong HS, Sharon L, Jasman A. 30


nd Jun

2014, Kuala Lumpur. 75. Blood pressure variability in patients undergoing haemodialysis with dialysate temperature 37C &

35C in acuate Dialyssi unit. Tye YL, Wong HS, Suryati Y, Goh CY, Boon CB, 30th Annual Congress

of Malaysian Society of Nephrology. 20-22nd

Jun 2014, Kuala Lumpur. 76. Ankle-Brachial index and vascular calcification: Is there a correlation? Hayana H, Anjalai C,

Zulhelmi A, Tan EZZ, Rafidah A, Wong HS. 30th Annual Congress of Malaysian Society of

Nephrology. 20-22nd

Jun 2014, Kuala Lumpur. 77. Survey on choice of modality of renal replacement therapy. An epidemiological data. MR Mohd

Hafiz, Suryati Yakob, Hin-Seng Wong, Loon Yi Tye, Sharifah Sarah. 30th Annual Congress of

Malaysian Society of Nephrology. 20-22nd

Jun 2014, Kuala Lumpur. 78. Survey on modality of renal replacement therapy. What influence the choice? MR Mohd Hafiz,

Suryati Yakob, Hin-Seng Wong, Loon Yi Tye, Norsyahida S. 30th Annual Congress of Malaysian

Society of Nephrology. 20-22nd

Jun 2014, Kuala Lumpur. 79. Impact of sodium intake on chronic haemodialysis patients in a single centre. J Surendiran, Zarina

H, Zulhelmi A, Suryati Y, Wong HS. 30th Annual Congress of Malaysian Society of Nephrology. 20-

22nd

Jun 2014, Kuala Lumpur. 80. Interventional counseling: Does it help chronic haemodialysis patients maintain their haemoglobin?

Faizah H, Shahnorani Ar, Harman H, Zulhelmi A, Suryati Y, Wong HS. 30th Annual Congress of

Malaysian Society of Nephrology. 20-22nd

Jun 2014, Kuala Lumpur. 81. Tuberculous and Non-tuberculous Mycobacterium Peritonitis: Single Centre Experience. Eddie

WFS, Alwyn CYZ, Esther T, Bee BC, Wong HS. 32nd

Annual Congress of Malaysian Society of Nephrology. 29

th April – 1

st May 2016, Johor Baru.

82. Successful Treatment of Fungal Peritonitis in Peritoneal Dialysis Patients by Intravenous and Intraperitoneal Administration of Amphotericin B with Oral Flucytosine. A Case Series. Lau SY, Bee BC, Goh CY, Wong HS. 32

nd Annual Congress of Malaysian Society of Nephrology. 29

th April – 1

st

May 2016, Johor Baru.

83. Is the ISPD Recommended Dosage of Intraperitoneal Aminoglycosides and Vancomycin appropriate for Asian Peritoneal Dialysis Patients with Peritonitis. Lau SY, Lee FY, Mohd Zaki ZJ, Roslan NI, Kuppusamy SK, Zamri SM, Poh V, Zakaria Z, Bee BC, Wong HS. 32

nd Annual

Congress of Malaysian Society of Nephrology. 29th April – 1


84. Comorbidities and survival in end stage renal disease with palliative care treatment : A three years Selayang Hospital experienced. Mohammad FA, Suryati Y, Wong HS, Siow YC. 32

nd Annual



85. Nonmedical Factors Influencing Decision for Palliative Care in Chronic Kidney Disease ( CKD ) Stage V. Mohammad FA, Suryati Y, Wong HS, Siow YC. 32

nd Annual Congress of Malaysian

Society of Nephrology. 29th April – 1


86. Outcome of lupus nephritis patients treated with double filtration plasmapheresis in Hospital Selayang:Single centre experience. Norazinizah AM, Suryati Y, EZZ Tan, Wong HS. 32

nd Annual



87. Long term efficacy and safety of CNI free regimen in Kidney Transplant Recipients with chronic allograft nephropathy. Eddie WFS, Mohammad FA, Wong HS, Suryati Y, Esther T, Shahidatul AI, Aimi SNSAZ. 19

th Scientific meeting of Malaysian Society of Transplantation.

27-29th

May 2016, Penang (2nd

prize for doctor category) 88. Is conversion from CNI to everolimus safe and effective in kidney transplant recipients with marked

allograft dysfunction. Eddie WFS, Mohammad FA, Wong HS, Suryati Y, Esther T, Shahidatul AI, Aimi SNSAZ. 19


th May 2016,

Penang 89. Accuracy of Estimated Post-Transplant Survival (EPTS) Score in predicting patient survival

post renal transplant in Malaysia. Phui VE, Wong HS, Suryati Y, Esther T, Goh CH, Jasmine AR. 20


th May 2017,

Melaka. (2nd

prize for doctor category) 90. Evaluating the predictive value of the Kidney donor profile index (KDPI) scores in graft

outcome after deceased donor kidney transplant in Malaysia. Phui VE, Wong HS, Chitra R, Eddie WFS, Khairul AR, Haninatul YO. 20

th Scientific meeting of Malaysian Society of

Transplantation. 12-13th

May 2017, Melaka (3rd

prize for doctor category) 91. Dose Response Relationship between Diltiazem and Tacrolimus in Renal Transplant

Recipients : A Pharmacokinetic Study. Choong CL, Wong HS, Lee FY, Lee CK, Kho JV, Lai YX, Vikneswaran T. 20


th

May 2017, Melaka. (1st

prize for paramedic category) 92. Does Introduction of Diltiazem to Reduce Tacrolimus Dosage Safe in Post-renal Transplant

Recipients? Choong CL, Wong HS, Lee FY, Lee CK, Kho JV, Lai YX, Vikneswaran T. 20th

Scientific meeting of Malaysian Society of Transplantation. 12-13

th May 2017, Melaka. (2

nd

prize for paramedic category) 93. Single Transplant Centre Experience: Survival Outcome of Deceased Donor Pediatric Kidney

Transplantation at Hospital Selayang Malaysia. Eddie WFS, Wong HS, Phui VE, Suryati Y, Esther TZZ, Goh CH. 20


th May 2017,

Melaka. 94. Tacrolimus Intra-patient Variability: The Impact and safety of conversion from Prograf

® to Advagraf

®

In Stable Kidney Transplant Recipients. Dheepa R, Wong HS, Suryati Y, Esther TZZ, Khairiyah I. 20


th May 2017, Melaka.

95. Oral / Poster Research Presentations at international scientific meeting 1. Anticoagulation of high risk patients on continuous veno-venous haemodialysis: a preliminary

report. Wong HS, Tan CC, Ghazali A, Zaki M. The 2nd

International Antithrombotic Therapy Symposium. 6

th June 1996. Seoul, Korea

2. Is CAPD better for Ischaemic heart disease? Lau SG, Wong HS, Tan CC, Lim TO, Zaki M. 2nd International Congress on Dialysis. 2

nd-5

th October 1996, Singapore.

3. Office haemodialysis in Malaysia. Ho CK, Wong HS, Tan CC, Lim TO, Zaki M, 2nd International Congress on Dialysis. 2

nd-5

th October 1996 Singapore.

4. CAPD peritonitis – Is the new antibiotic regime better? Ong LM, Wong HS, Zaki M. 2nd International Congress on Dialysis. 2

nd-5

th October 1996, Singapore.

5. Anticoagulation of high risk patients on continuous veno-venous haemodialysis. Wong HS, Zaki M. 12

th Asian Colloquium in Nephrology. 6-8

th August 1998, Kuala Lumpur, Malaysia.

6. Desferrioxamine therapy in haemodialysis patients with aluminum toxicity – Hospital Kuala Lumpur experience. Goh BL, Visvanathan R, Wong HS, Zaki M. 12

th Asian Colloquium in Nephrology. 6-8

th

August 1998, Kuala Lumpur, Malaysia.

7. Neoral (cyclosporin A) C2 monitoring in renal transplant recipients: A single Asian center experience. Hin-Seng Wong, Zaki Morad. 7

th Congress of the Asian Society of Transplantation. 2-

6th March 2002, New Delhi, India.

8. Variability of C2 (concentration at 2 hrs post dosing) concentration of Cyclosporin A (CSA) in renal transplant recipients: A single centre experience. H.S. Wong, Z. Morad. 7

th Congress of the Asian

Society of Transplantation. 2-6th March 2002, New Delhi, India.

9. Safety and efficacy of intravenous iron supplement (iron dextran) in patients on continuous ambulatory peritoneal dialysis. Tan PC, Wong HS, Zaki M. The First Asian Chapter Meeting: International Society for Peritoneal Dialysis. 13-15

th December 2002, Hong Kong.

10. Fungal Peritonitis in Continuous Ambulatory Peritonitis Dialysis (CAPD) Patients: A Single Center Experience. How, PC Tan, HS Wong, Z Morad. The First Asian Chapter Meeting: International Society for Peritoneal Dialysis. 13-15


11. A Randomised, Multi-center, Open label trial to establish the therapeutic equivalence between Carex

® and Ultra

® in patients on CAPD. Loke-Meng Ong, Teck-Onn Lim, Lai-Seong Hooi, Zaki

Morad, Poh-Choo Tan, Hin-Seng Wong, et al. The First Asian Chapter Meeting: International Society for Peritoneal Dialysis. 13-15


12. Aggressive calcium replacement regimen in preventing post parathyroidectomy hungry bone syndrome in patients with severe tertiary hyperparathypoidism. Hin-Seng Wong, Zaki Morad. World Congress of Nephrology, 8-12

th June 2003, Berlin, Germany

13. Body composition by bioelectrical impedance analysis in renal transplant recipients. Hin-Seng Wong, Lai-Mee Boey, Zaki Morad. 8

th Congress of the Asian Society of Transplantation. 23-27

th

September 2003, Kuala Lumpur, Malaysia. 14. Influence of pre-transplant dialysis modality in post living related renal transplant event. Shahnaz

Shah Firdaus Khan, Hin-Seng Wong, Zaki Morad. 8th Congress of the Asian Society of

Transplantation. 23-27th September 2003, Kuala Lumpur, Malaysia.

15. Incidence of hypercalcaemia over a period of one year following renal transplant. Shahnaz Shah Firdaus Khan, Hin-Seng Wong, Zaki Morad. 8

th Congress of the Asian Society of Transplantation.

23-27th September 2003, Kuala Lumpur, Malaysia.

16. Post transplantation diabetes mellitus in Asian renal transplant recipients. Siu-Mei Foo, Hin-Seng Wong, Zaki Morad. 8

th Congress of the Asian Society of Transplantation. 23-27

th September 2003,

Kuala Lumpur, Malaysia. 17. Conversion from mycophenolate mofetil to azathioprine in stable renal transplant recipients. Chen-

Hua Ching, Hin-Seng Wong, Zaki Morad. 8th Congress of the Asian Society of Transplantation. 23-

27th September 2003, Kuala Lumpur, Malaysia.

18. Quality of life in cadaver and living related renal transplant recipients in Kuala Lumpur Hospital. Alinda Chiu, Hin-Seng Wong, Zaki Morad. 8

th Congress of the Asian Society of Transplantation.

23-27th September 2003, Kuala Lumpur, Malaysia.

19. A Randomized, Multi-center, Open label trial to establish the therapeutic equivalence between ANDY-Disc

® (Fresenius Medical Care) and Ultrabag

® (Baxter) in patients on CAPD [CAPD-2 Trial].

Wong HS, Ong LM, Lim TO, Morad Z, Lim YN, Tan PC, et al. The 2nd

Asian Chapter Meeting: International Society for Peritoneal Dialysis. 22

nd - 25

th January 2005, Hyderabad, India

20. The effect of Bio Infrared energy in increasing access blood flow in native arteriovenous fistula. Hin-Seng Wong , Morad Z, 3

rd World Congress on Nephrology. 26

th – 30

th June 2005, Singapore.

21. Management of renal bone disease in accordance to K/DOQI guideline-a single center experience. Thian-Fook Chew, Hin-Seng Wong, Morad Z. 3


th – 30

th June

2005, Singapore. 22. Preliminary report of the use of C reactive protein and ESR in predicting peritoneal dialysis patient

outcome. Kuan Weng Go, Wong Hin Seng, Tan Poh Choo, Zaki Morad. 3rd

World Congress on Nephrology. 26

th – 30


23. Preliminary report of the use of bioelectrical impedance analysis in monitoring nutrition status and survival of peritoneal dialysis patients. Kuan Weng Go, Wong Hin Seng, Tan Poh Choo, Zaki Morad. 3


th – 30


24. Outcome of high risk renal biopsy: Comparing plug and non plug biopsy. Kee Liang Ong, Go Kuan Weng, Wong Hin Seng, Choo, Zaki Morad. 3


th – 30

th June

2005, Singapore.

25. Outcome of patient undergoing total parathyroidectomy for tertiary hyperparathyroidism with auto transplant compared with patients without autotransplant. Kuan Weng Go, Wong Hin Seng, Hisham AN, Zaki Morad. 3


th – 30


26. Randomised controlled trial on the use of pamidronate prior to total parathyroidectomy for high risk tertiary hyperparathyroidism patients. Kuan Weng Go, Wong Hin Seng, Hisham AN, Zaki Morad. 3


th – 30


27. Randomised controlled trial of pulse intravenous cyclophosphamide versus MMF in the induction therapy of proliferative lupus nephritis. Loke Meng Ong, Lai Seong Hooi, Teck Onn Lim, Bak Leong Goh, Ghazali Ahmad, Rozina Ghazalli, Sue Mei Teo, Hin Seng Wong, Si Yen Tan, Wan Shaariah, Chwee Choon Tan, Zaki Morad. 3


th – 30

th June 2005,

Singapore. 28. A novel technique of peritoneal access under direct peritoneoscopic vision with catheter sling. Bee

BC, Goh YH, Wong HS. The 3rd

Asian Chapter Meeting of the International Society for Peritoneal Dialysis. 22-24

th November 2007, Hiroshima, Japan

29. Treatment of haemodialysis patients with chronic hepatitis C using pegylated interferon alfa-2A (Pegasys®). N Zulkarnain Sim, A Chiu, HS Wong. 11

th Asian Pacific Congress of Nephrology. 5-8

th

May 2008, Kuala Lumpur, Malaysia 31. Outcomes of tunneled translumbar inferior vena cava haemodialysis catheters: A comparison

study. Kian-Seong Gan, Hin-Seng Wong, Boon-Cheak Bee, Rafidah Abdullah, Shahrina Man Harun, Ghazali Ahmad. 11


th May 2008, Kuala Lumpur,

Malaysia 32. Impact of conversion from one dialysis modality to another: A comparative study. Kian-Seong Gan,

Hin-Seng Wong, Boon-Cheak Bee, Rafidah Abdullah, Ghazali Ahmad, Koh-Wei Wong. 11th Asian

Pacific Congress of Nephrology. 5-8th May 2008, Kuala Lumpur, Malaysia

33. Short term infectious complications post renal transplant. CL Loh, YW Chow, KW Wong, WS Hii, SS Chin, YC Yap, YC Kueh, L Mushahar, S Bavanandan, R Yahya, R Visvananthan, HS Wong, G Ahmad. 11


th May 2008, Kuala Lumpur, Malaysia

34. The prevalence and risk factors of osteoporosis in renal transplant patients. Kian-Seong Gan, Hin-Seng Wong, Boon-Cheak Bee, Rafidah Abdullah, Ghazali Ahmad, Chitra Ramasamy. 11

th Asian

Pacific Congress of Nephrology. 5-8th May 2008, Kuala Lumpur, Malaysia

35. Real-time ultrasound guided renal biopsy. WS Hii, HS Wong, Ghazali Ahmad, Rafidah Abdullah, BC Bee. 11


th May 2008, Kuala Lumpur, Malaysia

36. A pharmacokinetic study on the effect of calcineurin inhibitors on mycophenolic acid trough level in stable adult renal transplant recipients. Hin-Seng Wong, Heong-Keong Goh, Suryati Yakob, Rafidah Abdullah, Boon-Cheak Bee. Asia Transplantation Immunology Forum 2010, 23-26

th Sept 2010, Suchow, China. (3

rd Prize)

38. Assisted versus selfcare peritoneal dialysis: A single centre experience. Mohamad Nor FS, Bee BC, Wong HS, Abdullah R, Goy CY, Aseervadam SL, Mohamed A. 14

th Congress of the

International Society for Peritoneal Dialysis, 9-12th Sept 2012, Kuala Lumpur, Malaysia

39. Risk factors and outcome of MRSA peritonitis: A single centre experience. Mohamad Nor FS, Bee BC, Mazlan SA, Tan EZZ, Wong HS, Abdullah R, Goy CY, Mat N. 14

th Congress of the


40. Outcome of SPICE peritonitis in PD patients: A single centre experience. Sadanah AM, Bee BC, Wong HS, Goh CY, Abdullah R, Fariz Safhan MN. 14

th Congress of the International Society for

Peritoneal Dialysis, 9-12th Sept 2012, Kuala Lumpur, Malaysia

41. Risk factors and outcome of fungal peritonitis: A single centre experience over a decade. Tan EZZ, Wong HS, Goh CY, Abdullah R, Mat N. 14

th Congress of the International Society for Peritoneal

Dialysis, 9-12th Sept 2012, Kuala Lumpur, Malaysia

42. Endoluminal brushing of non functioning tenckhoff catheter: Does it work. Tan EZZ, Bee BC, Wong HS, Goh CY, Abdullah R, Hashim H. 14



43. A tenckhoff catheter salvage technique for severe exit infection and tunnel infection using splicing and titanium extender: A preliminary report. Tan EZZ, Bee BC, Goh YH, Goh CY, Wong HS, Abdullah R. 14

th Congress of the International Society for Peritoneal Dialysis, 9-12

th Sept 2012,

Kuala Lumpur, Malaysia 44. Using catheter splicing and titanium extender for tenckhoff catheter that are damaged or cut at the

exit site: A preliminary report. Tan EZZ, Bee BC, Goh YH, Goh CY, Wong HS, Abdullah R. 14th

Congress of the International Society for Peritoneal Dialysis, 9-12

th Sept 2012, Kuala Lumpur,

Malaysia

45. Mycobacterium infection in peritoneal dialysis patients. A single centre experience in 5 years. Yakob S, Wong HS, Bee BC, Goh CY, Abdullah R. 14

th Congress of the International Society for

Peritoneal Dialysis, 9-12th Sept 2012, Kuala Lumpur, Malaysia

46. A retrospective study on outcomes of automated peritoneal dialysis versus continuous peritoneal dialysis. Nor FSM, Bee BC Abdullah R, Wong HS, Goh CY, Mohamed A, Yin LY. 14

th Congress of

the International Society for Peritoneal Dialysis, 9-12th Sept 2012, Kuala Lumpur, Malaysia

47. Positive versus negative selection of peritoneal dialysis: An analysis of outcome of a single centre. Mazlan SA, Wong HS, Bee BC, Goh CY, Abdullah R, Nor FSM, Nasir NMN. 14

th Congress of the


48. What is the target KT/V for Asian patients on peritoneal dialysis? Nor FSM, Wong HS, Bee BC, Abdullah R, Goh CY, Mat N, Ibrahim R. 14



49. Elderly versus non elderly end stage renal failure on peritoneal dialysis: An analysis on the outcome. Nor FSM, Bee BC, Wong HS, Abdullah R, Goh CY, Yakob S, Aseervadam SL, Yin LY. 14


th Sept 2012, Kuala

Lumpur, Malaysia (5th

Prize) 50. An analysis of peritoneal dialysis outcome in patients with diabetes mellitus: A single centre

experience. Nor FSM, Wong HS, Bee BC, Abdullah R, Goh CY, Tan EZZ, Sadanah AM, Mat N, Ibrahim R. 14


th Sept 2012,

Kuala Lumpur, Malaysia 51. Ultrasound Dilution Technique in Access Surveillance: Does it Predict Access Loss? Sarudin Z,

Jasman AM, Mohd Nizam I, Balasundram B, Rafidah A, Wong HS, Bee BC, Goh CY. Kuala Lumpur Vascular Access Conference 2012, 5-6

th October 2012, Kuala Lumpur

52. Treatment of proliferative lupus nephritis. A single centre experience in 10 years. Suryati Yakob, Hin-Seng Wong, Rafidah Abdullah, Esther Tan. World Congress of Nephrology 2013, 31-4

th June

2013, Hong Kong 53. Risk factors And Prevalence of Chronic Kidney Disease in HIV Seropositive Patients in Malaysia.

Esther Tan Zhao Zhi, Rafidah Abdullah, Hin-Seng Wong, Benedict Sim Lim Heng, Christopher Lee Kwok Choong. ISN World Congress of Nephrology 2013, 31-4

th June 2013, Hong Kong

54. Clinical outcome of unexplained pleural effusion in chronic PD patients. Cheong WS, Bee BC, Wong HS, Suryati y, Tan ZZ, Tye YL. ISN World Congress of Nephrology 2015, 13

th -17

th Mar

2015, Cape Town, South Africa 55. Catheter Related Blood Stream Infection: Risks Of Adverse Outcomes (CRBSI: ROAD OUT) -

a pilot study. SS Yew, Suryati Y, HS Wong. Dialysis Access Symposium 2015, 12-14th

June 2015, Seoul, Korea (Best Abstract Award)

56. Risk Factors Influencing Mortality In Dialysis Patients Hospitalised For Hypervolaemia in a tertiary hospital. Tye YL, Wong HS, Tan ZZ, Yakob S. 9

th International Congress of the International

Society of Haemodialysis 2015. 13-16th September 2015, Kuala Lumpur

57. Demography and outcome of dialysis patients hospitalized for hypervolumia. Tye YL, Wong HS, Tan ZZ, Yakob S. 9

th International Congress of the International Society of Haemodialysis 2015.

13-16th September 2015, Kuala Lumpur

58. Impact of CRBSI (Catheter Related Blood Stream Infection) on the duration of hospitalisation in a tertiary nephrology centre. Yew SS, Yakob S, HS Wong. 9

th International Congress of the

International Society of Haemodialysis 2015. 13-16th September 2015, Kuala Lumpur

59. Risk factors of mortality and septic metastasis in Catheter Related Blood Stream Infection (CRBSI). Yee SS, Yakob S, HS Wong. 9

th International Congress of the International Society of

Haemodialysis 2015. 13-16th September 2015, Kuala Lumpur

60. Epidemiology and Outcome of CRBSI (catheter related blood stream infection) in a tertiery nephrology centre. Yew SS, Yakob S, Wong HS. 9

th International Congress of the International

Society of Haemodialysis 2015. 13-16th September 2015, Kuala Lumpur

Publications

1. Renal Replacement Therapy – Practice Guidelines. Wong HS, Ghazali A, Zaki M. (ed) Kuala Lumpur 1999.

2. Cost Effectiveness evaluation of the Ministry of Health dialysis programme. Lim TO, Lim YN, Wong HS, Zaki M. et al. Med J Malaysia 1999;54: 442-452

3. Outcome assessment of the Ministry of Health dialysis programme. Lim TO, Lim YN, Wong HS, Zaki M. et al. Med J Malaysia 1999; 54: 459-470

4. Case Report: Cytomegalovirus induced gastric ulceration with gastrointestinal bleeding. Bavanandan S, Ganesananthan S, Wong HS, Kew ST, Morad Z et al. Med J. Malaysia 2000; 55: Supp A.

5. The losartan renal protective study – rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoint in NIDDM with the Angiotensin II Antagonist Losartan). Barry M Brenner et al for the RENAAL study investigators. J. Renin Angiotensin Aldosterone Sys. 2000; 4: 328-335

6. Neoral (cyclosporin A) C2 monitoring in renal transplant recipients: A single center experience. H. S. Wong & Z Morad. Transplantation Proceedings 2003; 35: 230-231

7. Aggressive calcium replacement regimen in preventing post parathyroidectomy hungry bone syndrome in patients with severe tertiary hyperparathypoidism. Hin-Seng Wong, Zaki Morad. Nephrol Dial Transplant 2003; 18 (Suppl 4) : 149

8. A Randomised, Multi-center, Open label trial to establish the therapeutic equivalence between Carex

® and Ultra

® in patients on CAPD. Loke-Meng Ong, Teck-Onn Lim, Lai-Seong Hooi, Zaki

Morad, Poh-Choo Tan, Hin-Seng Wong, et al. Peritoneal Dialysis International 2003; 23 (Suppl 2) : S139-S143.

9. Dialysis Survival. W. Shaariah, Hin-Seng Wong, Loke-Meng Ong, Hee-Wu Tan. In 11th Report of

the Malaysian Dialysis & Transplant Registry 2003. National Renal Registry, Malaysia; 2004 10. Body composition by bioelectrical impedance analysis in renal transplant recipients. H.S Wong,

L.M Boey, Z. Morad. Transplantation Proceedings 2004; 36(7):2186-2187 11. Post transplantation diabetes mellitus in Asian renal transplant recipients. S.Mei. Foo, H.S.

Wong, Z. Morad. Transplantation Proceedings 2004; 36(7):2139-2140 12. Quality of life in cadaver and living related renal transplant recipients in Kuala Lumpur Hospital.

A. Chiu, H.S. Wong, Z. Morad. Transplantation Proceedings 2004; 36(7):2130-2131 13. Death and survival on dialysis. Hin-Seng Wong, Loke-Meng Ong, W. Shaariah. In 12

th Report of

the Malaysian Dialysis & Transplant Registry 2004. National Renal Registry, Malaysia; 2005 14. Economic Evaluation of Centre Haemodialysis and Continuous Ambulatory Peritoneal Dialysis in

Ministry of Health Hospitals, Malaysia. Lai Seong Hooi, Teck Onn Lim, Adrian Goh, Hin Seng Wong, Chwee Choon Tan, Ghazali Ahmad, Zaki Morad. Nephrology 2005; 10 (1):25-32.

15. Prevention of renal failure: The Malaysian experience. Lai Seong Hooi, Hin Seng Wong, Zaki Morad. Kidney International 2005; 67(supp 94):pp S1-S5

16. Renal Replacement Therapy – Clinical Practice Guidelines. (2nd

Edition). Ghazali A, LS Hooi, YN Lim, LM Ong, Rozina G, CC Tan, Wan Shaariah, HS Wong, Zaki M. (ed) Kuala Lumpur 2005.

17. Randomised controlled trial of pulse intravenous cyclophosphamide versus MMF in the induction therapy of proliferative lupus nephritis. Loke Meng Ong, Lai Seong Hooi, Teck Onn Lim, Bak Leong Goh, Ghazali Ahmad, Rozina Ghazalli, Sue Mei Teo, Hin Seng Wong, Si Yen Tan, Wan Shaariah, Chwee Choon Tan, Zaki Morad. Nephrology 2005; 10(5):504-510

18. Death and survival on dialysis. Hin-Seng Wong, Loke-Meng Ong, W. Shaariah. In 13th Report of

the Malaysian Dialysis & Transplant Registry 2005. National Renal Registry, Malaysia; 2006 19. A randomised, multi-centre, open label trial to determine peritonitis rate, product defect and

technique survival between ANDY-Disc® and Ultrabag® in patients on CAPD. Hin-Seng Wong, Loke-Meng Ong, Teck-Onn Lim, et al. American Journal Kidney Disease 2006; 48(3): 464-472


the Malaysian Dialysis & Transplant Registry 2006. National Renal Registry, Malaysia; 2007 21. In reply: “Biased” comparison between ANDY-Disc® and Ultrabag® in patients on CAPD. . Hin-

Seng Wong, Loke-Meng Ong, Teck-Onn Lim, American Journal Kidney Disease 2007; 49(1): 172-172

22. Treatment of haemodialysis patients with chronic hepatitis C using pegylated interferon alfa-2A (Pegasys®). N Zulkarnain Sim, A Chiu, HS Wong. Nephrology 2008; 13 (Suppl 1): A53

23. Outcomes of tunneled translumbar inferior vena cava haemodialysis catheters: A comparison study. Kian-Seong Gan, Hin-Seng Wong, Boon-Cheak Bee, Rafidah Abdullah, Shahrina Man Harun, Ghazali Ahmad. Nephrology 2008; 13 (Suppl 1): A64

24. Impact of conversion from one dialysis modality to another: A comparative study. Kian-Seong Gan, Hin-Seng Wong, Boon-Cheak Bee, Rafidah Abdullah, Ghazali Ahmad, Koh-Wei Wong. Nephrology 2008; 13 (Suppl 1): A65

25. Short term infectious complications post renal transplant. CL Loh, YW Chow, KW Wong, WS Hii, SS Chin, YC Yap, YC Kueh, L Mushahar, S Bavanandan, R Yahya, R Visvananthan, HS Wong, G Ahmad. Nephrology 2008; 13 (Suppl 1): A81

26. The prevalence and risk factors of osteoporosis in renal transplant patients. Kian-Seong Gan, Hin-Seng Wong, Boon-Cheak Bee, Rafidah Abdullah, Ghazali Ahmad, Chitra Ramasamy. Nephrology 2008; 13 (Suppl 1): A83

27. Real-time ultrasound guided renal biopsy. WS Hii, HS Wong, Ghazali Ahmad, Rafidah Abdullah, BC Bee. Nephrology 2008; 13 (Suppl 1): A89


the Malaysian Dialysis & Transplant Registry 2007. National Renal Registry, Malaysia; 2008 29. A report of the Malaysian Dialysis Registry of the National Renal Registry, Malaysia. Y.N. Lim,

T.O. Lim, D.G. Lim, H.S. Wong, L.M. Ong, W. Shaariah, G. Rozina, Z. Morad. Med J Malaysia 2008;63: Suppl C, 5-8

30. Report of the Malaysian Registry of Renal Biopsy (MRRB). R. Yahya, S. Bavanandan, Y.C. Yap, W. Jazilah, W. Shaariah, H.S. Wong, D.G.Lee. Med J Malaysia 2008;63: Suppl C, 18-19


the Malaysian Dialysis & Transplant Registry 2008. National Renal Registry, Malaysia; 2009 32. Allograft renal biopsy. Hin-Seng Wong. In 1

st Report of the Malaysian Registry of Renal Biopsy

2007. National Renal Registry, Malaysia 2009 33. Death and survival on dialysis. Hin-Seng Wong, Loke-Meng Ong, W. Shaariah. In 17

th Report of

the Malaysian Dialysis & Transplant Registry 2009. National Renal Registry, Malaysia; 2010 34. Allograft renal biopsy. Hin-Seng Wong. In 2

nd Report of the Malaysian Registry of Renal Biopsy

2008. National Renal Registry, Malaysia 2010 35. Renal Replacement Therapy – Clinical Practice Guidelines. (3

rd Edition). Ghazali A, LS Hooi, YN

Lim, LM Ong, Rozina G, CC Tan, Wan Shaariah, HS Wong, (ed) Kuala Lumpur 2009. 36. Use of systemic corticosteroids and immunosuppressive agents. Wong HS. Rosnawati Yahya,

Manjulaa DS, Norehan Abdullah. In Malaysia Statistics on Medications 2007. Pharmaceutical Services Division, Ministry of Health Malaysia.

37. Death and survival on dialysis. Hin-Seng Wong, Loke-Meng Ong, In 18th Report of the Malaysian

Dialysis & Transplant Registry 2010. National Renal Registry, Malaysia; 2011 38. Renal transplantation. Goh BL, Wong HS, Fan KS, Johan RM, Yahya R, Menon SP, Tan SY. In

18th Report of the Malaysian Dialysis & Transplant Registry 2010. National Renal Registry,

Malaysia; 2011 39. Allograft renal biopsy. Hin-Seng Wong. In 3

rd Report of the Malaysian Registry of Renal Biopsy

2009. National Renal Registry, Malaysia 2011 40. Normalized bioimpedance indices are better predictors of outcome in peritoneal dialysis patients.

Koh KH, Wong HS, Go KW, Morad. Perit Dial Int 2011;31:574-582 41. Death and survival on dialysis. Hin-Seng Wong, Loke-Meng Ong, In 19

th Report of the Malaysian

Dialysis & Transplant Registry 2011. National Renal Registry, Malaysia; 2012 42. Renal transplantation. Goh BL, Fan KS, Johan RM, Yahya R, Menon SP, Tan SY, Wong HS. In



th Report of the Malaysian Registry of Renal Biopsy

2010. National Renal Registry, Malaysia 2012 44. Conversion to enteric coated Mycophenolate Sodium from Mycophenolate Mofetil in stable renal

transplant patients: Results of an Asia Pacific study. Lee PH, Vathsala A, Han DJ, Chan TM, Wong HS, Woodcock C, Kurstjens. Nephrology 2013;18:57-62

45. Use of systemic corticosteroids and immunosuppressive agents. Wong HS. Rosnawati Y, Ong SG, Syazzana, Puteri Juanitta Z. In Malaysian Statistics on Medicines 2008. Pharmaceutical Services Division & Clinical Research Centre, Ministry of Health Malaysia.

46. Death and survival on dialysis. Loke-Meng Ong, Hin-Seng Wong,, In 20th Report of the

Malaysian Dialysis & Transplant Registry 2012. National Renal Registry, Malaysia; 2013 47. Renal transplantation. Goh BL, Fan KS, Johan RM, Yahya R, Menon SP, Tan SY, Wong HS. In


Malaysia; 2013 48. Ratio of capacitance/BMI reflects deficit in nutritional concentration while CH2 reflects total

nutritional deficit in CAPD and general population. Keng-Hee Koh & Hin-Seng Wong. Open J Nephrol 2013,3:194-203

49. Pharmacogenotyping of CYP3A5 in predicting dose adjusted trough levels of tacrolimus among Malaysian kidney transplant patients. Hamzah S, Teh LK, Siew JS, Ahmad G, Wong HS, Zakaria ZA, Salleh. Can J Physiol Pharmacol 2014; 92(1):50-57

50. Death and survival on dialysis. Hin-Seng Wong, Loke-Meng Ong, In 21st Report of the Malaysian

Dialysis & Transplant Registry 2013. National Renal Registry, Malaysia; 2014

51. Renal transplantation. Goh BL, Fan KS, Yahya R, Menon SP, Tan SY, Wong HS, Johan RM. In 21

st Report of the Malaysian Dialysis & Transplant Registry 2013. National Renal Registry,


th Report of the Malaysian Registry of Renal Biopsy

2012. National Renal Registry, Malaysia 2014 53. Use of systemic corticosteroids and immunosuppressive agents. Wong HS. Rosnawati Y, and

Ong SG. In Malaysian Statistics on Medicines 2009 & 2010. Pharmaceutical Services Division & Clinical Research Centre, Ministry of Health Malaysia 2014.

54. Risk Factors Influencing Mortality In Dialysis Patients Hospitalised For Hypervolaemia in a tertiary hospital. Tye YL, Wong HS, Tan ZZ, Yakob S. Haemodialysis International 2015; 19 (Suppl 2):S62

55. Demography and outcome of dialysis patients hospitalized for hypervolumia. Tye YL, Wong HS, Tan ZZ, Yakob S. Haemodialysis International 2015; 19 (Suppl 2):S61

56. Impact of CRBSI (Catheter Related Blood Stream Infection) on the duration of hospitalisation in a tertiary nephrology centre. Yew SS, Yakob S, HS Wong. Haemodialysis International 2015; 19 (Suppl 2):S57

57. Risk factors of mortality and septic metastasis in Catheter Related Blood Stream Infection (CRBSI). Yee SS, Yakob S, HS Wong. Haemodialysis International 2015; 19 (Suppl 2):S58

58. Epidemiology and Outcome of CRBSI (catheter related blood stream infection) in a tertiery nephrology centre. Yew SS, Yakob S, Wong HS. Haemodialysis International 2015; 19 (Suppl 2):S57

59. Death and survival on dialysis. Hin-Seng Wong, Loke-Meng Ong, In 22st Report of the Malaysian

Dialysis & Transplant Registry 2014. National Renal Registry, Malaysia; 2015 60. The Cost and Utility of Renal Transplantation in Malaysia. Sunita Bavanandan, Yok-Chin Yap,

Ghazali Ahmad, Hin-Seng Wong, Soraya Azmi, Adrian Goh. Transplantation Direct 2015; 1(10):e45

Participation in Multi-centre International Trials 1. RENAAL (Reduction of Endpoint in NIDDM with the Angiotensin II Antagonist

Losartan) 2. MYPROMS (International Myfortic Prospective Multicentre Study) 3. Neoral - MOST (Multinational Observational Study in Transplantation) 4. ERL 2404 Freedom study (Free of steroid in renal transplantation study) 5. SHARP (Study of Heart and Renal Protection) 6. A multicenter randomized double blind study to evaluate the safety of

MK-0431 monotherapy in patients with type 2 DM and CRF who have inadequate glycaemic control

7. ASCERTAIN (Assessment of everolimus in additional to calcineurin inhibitors reduction in maintenance renal transplant recipients)

8. Aspreva Lupus Management Study 9. MK 0431 073: A multicenter randomized double blind study to evaluate the efficacy

and safety of sitagliptin versus glipizide in patients with type 2 DM and ESRD who are on dialysis & who have inadequate glycaemic control

10. MK 0431 063: A multicenter randomized double blind study to evaluate the efficacy and safety of sitagliptin versus glipizide in patients with type 2 DM and chronic renal insufficiency who have inadequate glycaemic control

11. GRID : Evaluation of Chronic Kidney Disease practice patterns through the Global information database

12. CERL080AMY02: Measurement of Patient Reported Outcomes in Renal Renal Transplant Patients with and without Gastrointestinal (GI) Symptoms (PROGIS)

13. BH 21260: A randomized, controlled, open-label, multi-centre, parallel-group study to assess all-cause mortality and cardiovascular morbidity in patients with chronic kidney disease on dialysis and those not on renal replacement therapy under treatment with MIRCERA

® or reference ESAs.

14. SHARP-ER (Study of Heart and Renal Protection Extended Review 15. B1261007: A phase 2 randomised, double blind, placebo controlled, parallel group,

multicentre study to evaluate the efficacy and safety of once daily administration of

1997 – 2000 2002 – 2004 2002 – 2004 2003 – 2005 2003 – 2008 2004 – 2006 2004 – 2008 2006 – 2008 2007 – 2009 2007 – 2009 2009 – 2012 2010 – 2011 2011 – 2017 2013 – 2016 2013 – 2014

a chemokine CCR2/5 receptor antagonist (PF-04634817) in adults with type 2 diabetes and overt nephropathy

16. ISN 0by25 Global Snapshot study 17. M11-353: A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-

Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy. (SONAR: Study Of Diabetic Nephropathy with Atrasentan)

18. TRANSFORM : Advancing renal transplant efficacy and safety outcome with an everolimus based regimen (RAD001A2433)

19. PD IDEA study 20. GSK ASCEND-ND: A phase 3, randomized, open-label, active-controlled, parallel

group, multicentre event driven study in non dialysis subjects with anaemia assoc with CKD to evaluate the safety & efficacy of daprodustat compared to darbepoetin

21. GSK ASCEND-D: A phase 3, randomized, open-label, active-controlled, parallel group, multicentre event driven study in dialysis subjects with anaemia assoc with CKD to evaluate the safety & efficacy of daprodustat compared to darbepoetin

2014 2014 – 2018 2014 – 2016 2016 – 2017 2017 – 2020 2017 – 2020

CURRICULUM VITAE Personal Informationdas2017-nagoya.org/archives/001/201706/7034316d2b7... ·...

Documents

Transcript of CURRICULUM VITAE Personal Informationdas2017-nagoya.org/archives/001/201706/7034316d2b7... ·...